Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 18, 2021
Global Healthcare Opportunities, or GHO Capital Partners LLP, has announced the acquisition of Genesis Research, a provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services.
read more
Wednesday, April 15, 2020
Cytel has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration.
read more
Wednesday, March 09, 2022
H Clinical announced that the company is expanding logistics service capabilities to support decentralized clinical trials (DCTs) in emerging markets throughout Latin America. Coordinated logistics and depots better facilitate multi-site and multi-...
read more
Norwich focuses on manufacturing potent, solid dose products, including fast dissolve and controlled release tablets, while also providing a range of analytical services in-house.
read more
Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services through its Contract Research Services (CRS) business, and Fluofarma, a contract research organization specializing in high content analysis, have ...
read more
Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services through its Contract Research Services(CRS) business, is prepared to meet the global demand for development programs in novel biologics and biosimilars.
read more
Headlands Research announced its acquisition of two large CNS-focused clinical research centers; JEM Research Institute and Toronto Memory Program.
read more
Headlands Research announced its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials.
read more
HealthVerity announced that it has been awarded a contract with the Centers for Disease Control and Prevention (CDC) to provide a large-scale, fully interoperable, real-world dataset to advance a wide range of COVID-19 research, decision making, and ...
read more
Wednesday, August 02, 2017
Helsinn and MEI Pharma announced the first patient has been dosed in the Phase 3 study of pracinostat in combination with azacitidine in adults with newly diagnosed AML who are unfit to receive intensive induction chemotherapy.
read more
Wednesday, April 15, 2020
Horizon Discovery announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE™ platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-...
read more
Wednesday, November 17, 2021
U.S.-based IACT Health and Canada-based LMC Manna Research announced a strategic alliance to integrate their operations. As two of the clinical research industry’s most extensive site networks, the alliance creates one of the largest consolidated ...
read more
The ICDD and the CCDC have announced a new partnership, which will allow greater utility and insights in the development of new drugs and materials.
read more
ICON plc announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and ...
read more
Saturday, September 25, 2021
The Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD announced that ICON, a Dublin-based global provider of drug development and commercialisation services to pharmaceutical, biotechnology and medical device industries, has...
read more